As of May 22
| -0.08 / -0.50%|
The 4 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 19.50, with a high estimate of 23.00 and a low estimate of 18.00. The median estimate represents a +23.03% increase from the last price of 15.85.
The current consensus among 4 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.